首页> 外文OA文献 >Role of glutaredoxin 2 and cytosolic thioredoxins in cysteinyl-based redox modification of the 20S proteasome
【2h】

Role of glutaredoxin 2 and cytosolic thioredoxins in cysteinyl-based redox modification of the 20S proteasome

机译:谷氧还蛋白2和细胞溶质硫氧还蛋白在20s蛋白酶体的半胱氨酰氧化还原修饰中的作用

摘要

The yeast 20S proteasome is subject to sulfhydryl redox alterations, such as the oxidation of cysteine residues (Cys-SH) into cysteine sulfenic acid (Cys-SOH), followed by S-glutathionylation (Cys-S-SG). Proteasome S-glutathionylation promotes partial loss of chymotrypsin-like activity and post-acidic cleavage without alteration of the trypsin-like proteasomal activity. Here we show that the 20S proteasome purified from stationary-phase cells was natively S-glutathionylated. Moreover, recombinant glutaredoxin 2 removes glutathione from natively or in vitro S-glutathionylated 20S proteasome, allowing the recovery of chymotrypsin-like activity and post-acidic cleavage. Glutaredoxin 2 deglutathionylase activity was dependent on its entry into the core particle, as demonstrated by stimulating S-glutathionylated proteasome opening. Under these conditions, deglutathionylation of the 20S proteasome and glutaredoxin 2 degradation were increased when compared to non-stimulated samples. Glutaredoxin 2 fragmentation by the 20S proteasome was evaluated by SDS-PAGE and mass spectrometry, and S-glutathionylation was evaluated by either western blot analyses with anti-glutathione IgG or by spectrophotometry with the thiol reactant 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole. It was also observed in vivo that glutaredoxin 2 was ubiquitinated in cellular extracts of yeast cells grown in glucose-containing medium. Other cytoplasmic oxido-reductases, namely thioredoxins 1 and 2, were also active in 20S proteasome deglutathionylation by a similar mechanism. These results indicate for the first time that 20S proteasome cysteinyl redox modification is a regulated mechanism coupled to enzymatic deglutathionylase activity.
机译:酵母20S蛋白酶体会发生巯基氧化还原改变,例如将半胱氨酸残基(Cys-SH)氧化为半胱氨酸亚磺酸(Cys-SOH),然后进行S-谷胱甘肽酰化(Cys-S-SG)。蛋白酶体S-谷胱甘肽酰化促进胰凝乳蛋白酶样活性的部分丧失和酸性后的裂解,而不会改变胰蛋白酶样蛋白酶体的活性。在这里,我们显示从固定相细胞纯化的20S蛋白酶体是天然S-谷胱甘肽化的。此外,重组谷胱甘肽毒素2从天然或体外S-谷胱甘肽化的20S蛋白酶体中去除了谷胱甘肽,从而恢复了胰凝乳蛋白酶样活性和酸性后的裂解。谷胱甘肽毒素2脱谷胱甘肽酶的活性取决于其进入核心颗粒,这通过刺激S-谷胱甘肽化的蛋白酶体的开放来证明。在这些条件下,与未刺激的样品相比,增加了20S蛋白酶体的脱谷胱甘肽化作用和glutaredoxin 2降解。通过SDS-PAGE和质谱评估20S蛋白酶体对Glutaredoxin 2的片段化作用,并通过抗谷胱甘肽IgG的蛋白质印迹分析或硫醇反应物7-chloro-4-nitrobenzo-2-的分光光度法评估S-谷胱甘肽化氧杂1,3-二唑在体内还观察到,在含有葡萄糖的培养基中生长的酵母细胞的细胞提取物中,谷胱甘肽毒素2被泛素化。其他细胞质氧化还原酶,即硫氧还蛋白1和2,也以类似的机制在20S蛋白酶体脱谷胱甘肽化中具有活性。这些结果首次表明20S蛋白酶体半胱氨酰氧化还原修饰是与酶促脱谷胱甘肽酶活性偶联的调节机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号